Advisory Board Members

Dr. Alexey Rak, Director of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D, France

Dr. Amitava Mukhopadhyay, Associate Director of Biostatistics, MorphoSys AG, Germany

Dr. Amrik Basran, CSO, Avacta Life Sciences, UK

Dr. Angelito Jonas L. Kalaw, Medical Director, PAREXEL International, Australia

Dr. Anthony W. Coleman, Research Director, University of Lyon, France

Dr. A. Hameed Khan, Senior Scientist, NCMRR (National Center for Medical Rehabilitation Research), National Institutes of Health (NIH), USA

Dr. Andreas Seidl, Chief Operating Officer, Leukocare AG, Germany

Dr. Balázs Sarkadi, Professor, Research Centre for Natural Sciences, Institute of Enzymology, Hungarian Academy of Sciences, Hungary

Dr. Beka Solomon, Professor, Tel-Aviv University, Israel

Dr. Chrissie Fletcher, Vice President of Biostatistics, GSK, UK

Dr. Dulcie A. Mulholland, Professor, University of Surrey, UK

Dr. Emilia Barcia, Professor, University Complutense of Madrid, Spain

Dr. Eduard Korkotian, Professor, The Weizmann Institute of Science, Israel

Dr. Florian Montel, Head of opnMe.com and CNS Project Leader in Medicinal Chemistry, Boehringer Ingelheim, Germany

Dr. Graham Ball, Professor of Bioinformatics/CSO, Nottingham Trent University/CompanDX, UK

Dr. John D. Chappell, Application & Service Director EMEA and Asia Pacific, Gyros Protein Technology, UK

Dr. John Gu, President and Chief Scientific Officer, Renascions, USA

Dr. Laurent Counillon, Professor, University of Nice-Sophia Antipolis, France

Dr. Loui Madakamutil, SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA

Dr. Marian Paluch, Professor, University of Silesia, Poland

Dr. Matthias von Herrath, Scientific Director of the Diabetes Research Institute, University of Miami School of Medicine; Vice President, Novo Nordisk, USA

Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK

Dr. Minying Cai, Professor, Department of Chemistry & Biochemistry, University of Arizona, USA

Dr. Natalie Pankova, Chief Operating Officer, Metadvice Ltd, UK

Dr. Ping Yang, CEO & Chairman, Synbio Technologies LLC, USA

Dr. Shanavaz Nasarabadi, President & Director R&D, GenTegra LLC, USA

Dr. Stefan J. Scherer, CEO and President, 3T Biosciences, USA

Dr. Wai Hong (Kevin) Lo, Associate Professor, University of Connecticut Health Center, USA

Dr. William C. Maier, Chief Scientific Officer & Head, Rare Disease Research, Commercialisation and Outcomes Division, ICON Plc, UK

Dr. Yaakov Naparstek, Chairman of Medicine, Hadassah University Hospital, Israel

Dr. Yaguang Xi, Professor and Department Head, University of Georgia, USA

Dr. Yukio Yoneda, Invited Professor, Osaka University, Japan

Dr. Yong Zhu, Associate Professor, Yale University School of Public Health; Assistant Director, Yale Cancer Center for Global Cancer Epidemiology, USA